Skip to main content

MUCUS RELIEF

NDC 51316-470 · CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED

Generic nameguaifenesin
Dosage formTABLET, MULTILAYER, EXTENDED RELEASE
RouteORAL
Active ingredient(s)GUAIFENESIN
Strength600 mg/1
Pharmacologic classDecreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
Marketing categoryANDA

Packages

51316-470-01 — 1 BLISTER PACK in 1 CARTON (51316-470-01) / 20 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACK

51316-470-02 — 5 BLISTER PACK in 1 CARTON (51316-470-02) / 20 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACK

51316-470-49 — 2 BLISTER PACK in 1 CARTON (51316-470-49) / 20 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACK

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

51316-293 — acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, 51316-299 — guaifenesin, 51316-304 — Dextromethorphan HBr, Guaifenesin, 51316-305 — Dextromethorphan HBr, Guaifenesin, 51316-310 — Dextromethorphan HBr, Guaifenesin, 51316-323 — Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, 51316-345 — guaifenesin, pseudoephedrine hydrochloride, 51316-389 — Dextromethorphan HBr, Guaifenesin, 51316-400 — guaifenesin, 51316-437 — Guaifenesin, 51316-473 — dextromethorphan hydrobromide, guaifenesin, 51316-500 — Dextromethorphan HBr, Guaifenesin, 51316-516 — Acetaminophen, Guaifenesin, Phenylephrine HCl, 51316-520 — guaifenesin, 51316-525 — Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 51316-530 — Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 51316-546 — Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 51316-552 — Dextromethorphan HBr, Guaifenesin, 51316-600 — Guaifenesin and Dextromethorphan Hydrobromide, 51316-613 — acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, +1437 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels